FOLH1 and prostate carcinoma: Live PSMA-positive (LNCaP) prostate cancer cells showed a reduced T2 relaxation time when treated with the muJ591:MIRB complex (Figure 9), and T2 was faster for higher concentrations of the antibody (equivalent to a higher concentration of iron).